Reference prices: The Spanish way

Fuente: Redalyc
Enregistré dans:
Détails bibliographiques
Auteur principal: Jorge Mestre Ferrándiz
Format: Artículo científico
Langue:en
Publié: Fundación SEPI 2003
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1876433809199595520
author Jorge Mestre Ferrándiz
author_facet Jorge Mestre Ferrándiz
contents Reference prices: The Spanish way Jorge Mestre Ferrándiz Economía y Finanzas generics copayments Reference prices pharmaceutical industry The aim of this paper is to analyse the e��ects of recent regulatory reformsimplemented in the Spanish pharmaceutical market: the promotion of genericdrugs and the implementation of reference prices. The objectives of suchreforms are twofold: firstly, to increase price competition and secondly, toreduce public pharmaceutical costs. This paper shows that for the Spanishmethod of implementing reference prices to achieve these objectives, comparedto a situation with copayments, requires the reference price to be set in acertain interval. In addition, the Spanish system may result in profits for thebranded and generic producers being reduced. 2003 artículo científico 0210-1521 https://www.redalyc.org/articulo.oa?id=17327105 en http://www.redalyc.org/revista.oa?id=173 Investigaciones Económicas application/pdf Fundación SEPI Investigaciones Económicas (España) Num.1 Vol.XXVII
format Artículo científico
id redalyc_17327105
institution Redalyc
language en
publishDate 2003
publisher Fundación SEPI
spellingShingle Reference prices: The Spanish way
Jorge Mestre Ferrándiz
Economía y Finanzas
generics
copayments
Reference prices
pharmaceutical industry
Reference prices: The Spanish way Jorge Mestre Ferrándiz Economía y Finanzas generics copayments Reference prices pharmaceutical industry The aim of this paper is to analyse the e��ects of recent regulatory reformsimplemented in the Spanish pharmaceutical market: the promotion of genericdrugs and the implementation of reference prices. The objectives of suchreforms are twofold: firstly, to increase price competition and secondly, toreduce public pharmaceutical costs. This paper shows that for the Spanishmethod of implementing reference prices to achieve these objectives, comparedto a situation with copayments, requires the reference price to be set in acertain interval. In addition, the Spanish system may result in profits for thebranded and generic producers being reduced. 2003 artículo científico 0210-1521 https://www.redalyc.org/articulo.oa?id=17327105 en http://www.redalyc.org/revista.oa?id=173 Investigaciones Económicas application/pdf Fundación SEPI Investigaciones Económicas (España) Num.1 Vol.XXVII
title Reference prices: The Spanish way
topic Economía y Finanzas
generics
copayments
Reference prices
pharmaceutical industry
url https://www.redalyc.org/articulo.oa?id=17327105